MARYSA WALLACE: Open Payments
NPI 1932989357 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,806 in 69 payments from 32 companies in 2025. Trend: 2023 $173 · 2024 $1,794 · 2025 $2,806
Food & beverage: $2,806
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $416 |
| Daiichi Sankyo Inc. | 5 | $257 |
| AstraZeneca Pharmaceuticals LP | 5 | $214 |
| JAZZ PHARMACEUTICALS INC. | 3 | $209 |
| Merck Sharp & Dohme LLC | 3 | $192 |
| E.R. Squibb & Sons, L.L.C. | 2 | $192 |
| BeOne Medicines USA, Inc. | 3 | $185 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| Geron Corporation | 1 | $125 |
| Genentech USA, Inc. | 4 | $80 |
Products named: RYBREVANT, Enhertu, ZEPZELCA, REBLOZYL, KEYTRUDA, BRUKINSA, RYTELO, IMFINZI.
Industry payments across GA — which companies pay providers there.
